Exploiting the transcriptional dependency of cancer cells (here mainly directed by two well‐known DNA‐binding proteins: ASCL1 and NEUROD1) as an Achilles’s heel to thwart their own tumorigenic potential, represents a key actionable mechanism against SCLC. This evidence concerns the gene ASCL1 and small cell lung carcinoma.